1. Home
  2. FAMI vs MIRM Comparison

FAMI vs MIRM Comparison

Compare FAMI & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAMI
  • MIRM
  • Stock Information
  • Founded
  • FAMI 2015
  • MIRM 2018
  • Country
  • FAMI China
  • MIRM United States
  • Employees
  • FAMI N/A
  • MIRM N/A
  • Industry
  • FAMI Packaged Foods
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • FAMI Consumer Staples
  • MIRM Health Care
  • Exchange
  • FAMI Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • FAMI 2.1M
  • MIRM 1.9B
  • IPO Year
  • FAMI 2018
  • MIRM 2019
  • Fundamental
  • Price
  • FAMI $1.78
  • MIRM $41.31
  • Analyst Decision
  • FAMI
  • MIRM Strong Buy
  • Analyst Count
  • FAMI 0
  • MIRM 11
  • Target Price
  • FAMI N/A
  • MIRM $58.55
  • AVG Volume (30 Days)
  • FAMI 94.9K
  • MIRM 437.9K
  • Earning Date
  • FAMI 05-06-2025
  • MIRM 05-12-2025
  • Dividend Yield
  • FAMI N/A
  • MIRM N/A
  • EPS Growth
  • FAMI N/A
  • MIRM N/A
  • EPS
  • FAMI N/A
  • MIRM N/A
  • Revenue
  • FAMI $64,131,332.00
  • MIRM $336,888,000.00
  • Revenue This Year
  • FAMI N/A
  • MIRM $29.51
  • Revenue Next Year
  • FAMI N/A
  • MIRM $20.27
  • P/E Ratio
  • FAMI N/A
  • MIRM N/A
  • Revenue Growth
  • FAMI N/A
  • MIRM 80.76
  • 52 Week Low
  • FAMI $1.43
  • MIRM $23.83
  • 52 Week High
  • FAMI $11.28
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • FAMI 47.41
  • MIRM 47.80
  • Support Level
  • FAMI $1.55
  • MIRM $38.22
  • Resistance Level
  • FAMI $1.98
  • MIRM $39.87
  • Average True Range (ATR)
  • FAMI 0.14
  • MIRM 2.08
  • MACD
  • FAMI 0.05
  • MIRM 0.34
  • Stochastic Oscillator
  • FAMI 57.71
  • MIRM 70.54

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: